BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21671749)

  • 1. Distinct functional effects for dynamin 3 during megakaryocytopoiesis.
    Wang W; Gilligan DM; Sun S; Wu X; Reems JA
    Stem Cells Dev; 2011 Dec; 20(12):2139-51. PubMed ID: 21671749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamin 3 participates in the growth and development of megakaryocytes.
    Reems JA; Wang W; Tsubata K; Abdurrahman N; Sundell B; Tijssen MR; van der Schoot E; Di Summa F; Patel-Hett S; Italiano J; Gilligan DM
    Exp Hematol; 2008 Dec; 36(12):1714-27. PubMed ID: 19007685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin IIA is critical for organelle distribution and F-actin organization in megakaryocytes and platelets.
    Pertuy F; Eckly A; Weber J; Proamer F; Rinckel JY; Lanza F; Gachet C; Léon C
    Blood; 2014 Feb; 123(8):1261-9. PubMed ID: 24243973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity.
    Suraneni PK; Corey SJ; Hession MJ; Ishaq R; Awomolo A; Hasan S; Shah C; Liu H; Wickrema A; Debili N; Crispino JD; Eklund EA; Chen Y
    Blood Adv; 2018 Dec; 2(23):3540-3552. PubMed ID: 30538113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of environmental stiffness for megakaryocyte differentiation and proplatelet formation.
    Aguilar A; Pertuy F; Eckly A; Strassel C; Collin D; Gachet C; Lanza F; Léon C
    Blood; 2016 Oct; 128(16):2022-2032. PubMed ID: 27503502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdc42-dependent F-actin dynamics drive structuration of the demarcation membrane system in megakaryocytes.
    Antkowiak A; Viaud J; Severin S; Zanoun M; Ceccato L; Chicanne G; Strassel C; Eckly A; Leon C; Gachet C; Payrastre B; Gaits-Iacovoni F
    J Thromb Haemost; 2016 Jun; 14(6):1268-84. PubMed ID: 26991240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.
    Panuganti S; Schlinker AC; Lindholm PF; Papoutsakis ET; Miller WM
    Tissue Eng Part A; 2013 Apr; 19(7-8):998-1014. PubMed ID: 23190353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal role of PDK1 in megakaryocyte cytoskeletal dynamics and polarization during platelet biogenesis.
    Geue S; Aurbach K; Manke MC; Manukjan G; Münzer P; Stegner D; Brähler C; Walker-Allgaier B; Märklin M; Borst CE; Quintanilla-Fend L; Rath D; Geisler T; Salih HR; Seizer P; Lang F; Nieswandt B; Gawaz M; Schulze H; Pleines I; Borst O
    Blood; 2019 Nov; 134(21):1847-1858. PubMed ID: 31578203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of actin polymerization by tropomodulin-3 controls megakaryocyte actin organization and platelet biogenesis.
    Sui Z; Nowak RB; Sanada C; Halene S; Krause DS; Fowler VM
    Blood; 2015 Jul; 126(4):520-30. PubMed ID: 25964668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-125a-5p regulates megakaryocyte proplatelet formation via the actin-bundling protein L-plastin.
    Bhatlekar S; Manne BK; Basak I; Edelstein LC; Tugolukova E; Stoller ML; Cody MJ; Morley SC; Nagalla S; Weyrich AS; Rowley JW; O'Connell RM; Rondina MT; Campbell RA; Bray PF
    Blood; 2020 Oct; 136(15):1760-1772. PubMed ID: 32844999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation.
    Mazharian A; Ghevaert C; Zhang L; Massberg S; Watson SP
    Blood; 2011 May; 117(19):5198-206. PubMed ID: 21385851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation.
    Huang J; Huang S; Ma Z; Lin X; Li X; Huang X; Wang J; Ye W; Li Y; He D; Yang M; Pan J; Ling Q; Li F; Mao S; Wang H; Wang Y; Jin J
    Thromb Haemost; 2021 Feb; 121(2):192-205. PubMed ID: 32961571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation.
    Eckly A; Strassel C; Freund M; Cazenave JP; Lanza F; Gachet C; Léon C
    Blood; 2009 Apr; 113(14):3182-9. PubMed ID: 18984861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes.
    Shin JW; Swift J; Spinler KR; Discher DE
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11458-63. PubMed ID: 21709232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase calpha.
    Rojnuckarin P; Kaushansky K
    Blood; 2001 Jan; 97(1):154-61. PubMed ID: 11133755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of inhibitor of Src kinases, SU6656, on differentiation of megakaryocytic progenitors and activity of alpha1,6-fucosyltransferase.
    Kaminska J; Klimczak-Jajor E; Skierski J; Bany-Laszewicz U
    Acta Biochim Pol; 2008; 55(3):499-506. PubMed ID: 18854874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation.
    Machlus KR; Wu SK; Stumpo DJ; Soussou TS; Paul DS; Campbell RA; Kalwa H; Michel T; Bergmeier W; Weyrich AS; Blackshear PJ; Hartwig JH; Italiano JE
    Blood; 2016 Mar; 127(11):1468-80. PubMed ID: 26744461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease.
    Pal K; Nowak R; Billington N; Liu R; Ghosh A; Sellers JR; Fowler VM
    Blood; 2020 May; 135(21):1887-1898. PubMed ID: 32315395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human endometrial stromal stem cells differentiate into megakaryocytes with the ability to produce functional platelets.
    Wang J; Chen S; Zhang C; Stegeman S; Pfaff-Amesse T; Zhang Y; Zhang W; Amesse L; Chen Y
    PLoS One; 2012; 7(8):e44300. PubMed ID: 22952951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abnormal proplatelet formation in MYH9-related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition.
    Chen Y; Boukour S; Milloud R; Favier R; Saposnik B; Schlegel N; Nurden A; Raslova H; Vainchenker W; Balland M; Nurden P; Debili N
    J Thromb Haemost; 2013 Dec; 11(12):2163-75. PubMed ID: 24165359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.